Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Internal Medicine Specialist
MBBS, Diplomate American Board Internal Medicine, Diplomate American Board Endocrinology, Diabetes & Metabolism
Gastroenterologist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MCPS
Diabetologist
MBBS, Dip in Diabetics
General Physician
MBBS, PG (Diabetes)
Rheumatologist
MBBS, MRCP (UK), FCPS (Medicine), FCPS (Rheumatology)
Consultant Physician
American Board of Internal Medicine (USA), MBBS, Fellowship in Gastroenterology
Consultant Physician
American Board of Internal Medicine (USA), MBBS, Fellowship in Gastroenterology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures